Time of insemination and its effect on in-vitro fertilization, cleavage and pregnancy rates in GnRH agonist/HMG-stimulated cycles.
In this prospective study, we compared the effect of delayed inseminations on fertilization, cleavage and pregnancy rates in two groups of patients. In one group, the ovarian stimulation was performed with a clomiphene citrate/human menopausal gonadotrophin/human chorionic gonadotrophin (CC/HMG/HCG) protocol. The other group was pre-treated with gonadotrophin-releasing hormone agonist (GnRHa) and ovarian stimulation was carried out with an HMG/HCG protocol. Under both protocols, a delay of 2, 4 or 6 h in insemination showed no significant differences in the fertilization, cleavage or pregnancy rates. To find out which type of oocyte has the potential for better fertilization, cleavage and implantation, a simple oocyte classification scheme is proposed. In the GnRHa/HMG group, 9% post-mature, 90% mature and only 1% immature oocytes were retrieved. The post-mature oocytes showed a tendency towards reduced fertilization when insemination was delayed. The mature and slightly immature oocytes fertilized equally well when spermatozoa were added 2, 4 or 6 h after retrieval. Similarly, no significant difference was observed in the cleavage (80%) or fragmentation (20%) rates of these oocytes. The pregnancy rates after inseminations delayed for 2, 4 and 6 h were 14, 27 and 26%, respectively. Though these figures were not statistically significant, the 4- and 6-h groups in both the IVF and zygote intra-Fallopian transfer treatments showed a slightly improved pregnancy rate compared to the 2-h group. An insemination delay of 4 h is advocated on a routine basis.
Khan
I
I
Centre for Reproductive Medicine, Academic Hospital, Vrije Universiteit Brussel, Belgium.
Staessen
C
C
Van den Abbeel
E
E
Camus
M
M
Wisanto
A
A
Smitz
J
J
Devroey
P
P
Van Steirteghem
A C
AC
D000328:Adult; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D002970:Cleavage Stage, Ovum / Q000187:drug effects; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D007314:Insemination; D008297:Male; D008596:Menotropins / Q000494:pharmacology*; D008597:Menstrual Cycle / Q000187:drug effects; D009865:Oocytes / Q000187:drug effects; D010062:Ovulation Induction; D010906:Pituitary Hormone-Releasing Hormones / Q000502:physiology; D011247:Pregnancy; D011446:Prospective Studies; D013997:Time Factors
D006063:Chorionic Gonadotropin; D010906:Pituitary Hormone-Releasing Hormones; D008596:Menotropins